A Study on Immune Cell Infiltration in Lung Adenocarcinoma

Author:

Zhao Hongwen1,Sun Bingqing1ORCID

Affiliation:

1. Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of China Medical University, Shenyang 110001, China

Abstract

Background: As a vital part of the tumor environment, immune cells affect the progression of tumors, and their composition and role vary in different types of tumors and influence prognosis. These immune cells have the potential to be beneficially targeted for immunotherapy, or, conversely, they may react negatively, even leading to drug resistance. For these reasons, probing into the composition and possible effects of immune cells in lung cancer is conducive to discovering valuable therapeutic targets. Materials and Methods: The lung adenocarcinoma gene expression data were downloaded from the TCGA database (https://cancergenome.nih.gov/; https://portal.gdc.cancer.gov/), and the lung adenocarcinoma gene expression matrix was converted into an immune cell-matrix using CIBERSORT software (https://cibersort.stanford.edu/), followed by an analysis of immune cells in lung adenocarcinoma tissues. Results: The results showed that among all immune cells in lung adenocarcinoma tissues, macrophages (Mφ) had the highest number, followed by T cells. The number of plasma cells in lung adenocarcinoma tissues was higher than in adjacent normal tissues. Compared with those in adjacent normal tissues, the number of resting memory clusters of differentiation 4 (CD4)+ T cells was lower, whereas active memory CD4+ T cells were higher in lung adenocarcinoma tissues. In addition, the number of CD8+ T cells was negatively related to that of resting memory CD4+ T cells, with a correlation coefficient of -0.44, whereas it showed a positive association with the number of active memory CD4+ T cells, with a correlation coefficient of 0.47. It was found that among various immune cells infiltrating lung adenocarcinoma tissues, unstimulated Mφ (M0), alternatively activated Mφ (M2), and resting memory CD4+ T cells accounted for the largest proportions. However, these three types of immune cells were found to be lower in lung adenocarcinoma tissues than in adjacent normal tissues. Conclusion: Immune cells infiltrating lung adenocarcinoma tissues are complex, which affect the development and progression of the tumor and may also be a significant cause of drug resistance. Studying the changes in immune cell infiltration during the development of specific types of tumors contributes to disease progression interpretation, prognosis assessment, and potential solutions to the existing drug resistance issue. In this paper, the status of immune cells in lung adenocarcinoma tissues was preliminarily discussed based on the database mining, but more experimental studies and in-depth discussions are needed in the future.

Funder

National Natural Science Foundation of China

Project of Liaoning Distinguished Professor

Publisher

Bentham Science Publishers Ltd.

Subject

Organic Chemistry,Computer Science Applications,Drug Discovery,General Medicine

Reference56 articles.

1. Zheng X.; Hu Y.; Yao C.; The paradoxical role of tumor-infiltrating immune cells in lung cancer. Intractable Rare Dis Res 2017,6(4),234-241

2. Domingues P.; González-Tablas M.; Otero Á.; Pascual D.; Miranda D.; Ruiz L.; Sousa P.; Ciudad J.; Gonçalves J.M.; Lopes M.C.; Orfao A.; Tabernero M.D.; Tumor infiltrating immune cells in gliomas and meningiomas. Brain Behav Immun 2016,53,1-15

3. Oliver A.J.; Lau P.K.H.; Unsworth A.S.; Loi S.; Darcy P.K.; Kershaw M.H.; Slaney C.Y.; Tissue-dependent tumor microenvironments and their impact on immunotherapy responses. Front Immunol 2018,9,70

4. Parra E.R.; Villalobos P.; Behrens C.; Jiang M.; Pataer A.; Swisher S.G.; William W.N.; Zhang J.; Lee J.; Cascone T.; Heymach J.V.; Forget M.A.; Haymaker C.; Bernatchez C.; Kalhor N.; Weissferdt A.; Moran C.; Zhang J.; Vaporciyan A.; Gibbons D.L.; Sepesi B.; Wistuba I.I.; Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches. J Immunother Cancer 2018,6(1),48

5. Gaudreau P.O.; Negrao M.V.; Mitchell K.G.; Reuben A.; Corsini E.M.; Li J.; Karpinets T.V.; Wang Q.; Diao L.; Wang J.; Federico L.; Parra-Cuentas E.R.; Khairullah R.; Behrens C.; Correa A.M.; Gomez D.; Little L.; Gumbs C.; Kadara H.N.; Fujimoto J.; McGrail D.J.; Vaporciyan A.A.; Swisher S.G.; Walsh G.; Antonoff M.B.; Weissferdt A.; Tran H.; Roarty E.; Haymaker C.; Bernatchez C.; Zhang J.; Futreal P.A.; Wistuba I.I.; Cascone T.; Heymach J.V.; Sepesi B.; Zhang J.; Gibbons D.L.; Neoadjuvant chemotherapy in-creases cytotoxic T cell, tissue resident memory T cell, and B cell infiltration in resectable NSCLC. J Thorac Oncol 2021,16(1),127-139

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3